The results revealed that the inhibition of YAP results in a marked anti-tumor effect in CML [129], and the inhibitory effect of shRNA and VP on YAP function in HL-60 cells was also reported. This evidence concerns the gene YAP1 and chronic myelogenous leukemia, BCR-ABL1 positive.